Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture (2015)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1016/j.biopsych.2015.03.008
- Subjects: LÍTIO; CULTURA DE CÉLULAS; ADJUVANTES IMUNOLÓGICOS; NEURÔNIOS; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Título: Biological psychiatry
- ISSN: 0006-3223
- Volume/Número/Paginação/Ano: v. 77, n. 9, suppl. 1, p. 413S, abst. 1129, 2015
- Conference titles: Annual Scientific Convention and Meeting of the Society of Biological Psychiatry
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DE-PAULA, Vanessa J. R. et al. Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture. Biological psychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.biopsych.2015.03.008. Acesso em: 09 jan. 2026. , 2015 -
APA
De-paula, V. J. R., Gattaz, W. F., Forlenza, O. V., & Mulsant, B. H. (2015). Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture. Biological psychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.biopsych.2015.03.008 -
NLM
De-paula VJR, Gattaz WF, Forlenza OV, Mulsant BH. Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture [Internet]. Biological psychiatry. 2015 ; 77( 9): 413S.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1016/j.biopsych.2015.03.008 -
Vancouver
De-paula VJR, Gattaz WF, Forlenza OV, Mulsant BH. Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture [Internet]. Biological psychiatry. 2015 ; 77( 9): 413S.[citado 2026 jan. 09 ] Available from: https://doi.org/10.1016/j.biopsych.2015.03.008 - Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
- Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
Informações sobre o DOI: 10.1016/j.biopsych.2015.03.008 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
